Eric R. Olson, Chief Scientific Officer at Syros Pharmaceuticals, Inc. (SYRS), sold 15,750 shares at $13.00 ($205K) on 2020-08-18, disclosed to the SEC on 2020-08-19.
Open-market sale of $205k SYRS by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $13.00 | 4,963 | $65K | 31.5% |
| 2 | $13.00 | 10,787 | $140K | 68.5% |
| Total | $13.00 avg | 15,750 | $205K | 100% |
| Filing → |
| SYRS | SELL | 2021-07-01 | $6K | — | Filing → |
| SYRS | SELL | 2021-03-17 | $34K | — | Filing → |
| SYRS | SELL | 2020-07-07 | $21K | — | Filing → |